See
Genome Information for Homo sapiens
This pharmacogenomic study focused on the response of patients with MDD to an 8-week course of treatment with citalopram or escitalopram. Briefly, clinical assessments and research assessments were performed at each study visit as summarized in Table 1. Many patients continued on antidepressant medication after the 8 week study. Table 1: Study timeline and patient contacts.
| Week | Consent/Med Hx | Write Rx | SI Qx | SCID | HRS-D17 | QIDSC16 | CGI-I |
| 0 | SC | RC | RC | SC | SC | SC | |
| 4 | | RC | RC | | SC | SC | RC |
| 8 | | RC | RC | | SC | SC | RC |
HRS-D17=Hamilton Rating Scale for Depression, QIDS-C16=Quick Inventory of Depressive Symptomatology, CGI... (for more see dbGaP study page.)
| Accession | PRJNA222873; dbGaP: phs000670 |
| Type | Umbrella project (Subtype:Authorized Access) |
| Organism | Homo sapiens[Taxonomy ID: 9606] Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo; Homo sapiens |
| Submission | Registration date: 18-Oct-2013
NIGMS |
| Relevance | Medical |
Project Data:
| Resource Name | Number
of Links |
|---|
| BioSample | 529 |
| Genotype and Phenotype (dbGaP) | 1 |
Homo sapiens encompasses the following sub-project:
| Project Type | Number of Projects |
| Phenotype or Genotype | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA222874 | Homo sapiens | Pharmacogenomics Research Network Antidepressant Medication Pharmacogenomic Study (PGRN-AMPS) (MAYO CLINIC) |
|